108 related articles for article (PubMed ID: 14758013)
1. Synthesis of 1-benzothiepine and 1-benzazepine derivatives as orally active CCR5 antagonists.
Aramaki Y; Seto M; Okawa T; Oda T; Kanzaki N; Shiraishi M
Chem Pharm Bull (Tokyo); 2004 Feb; 52(2):254-8. PubMed ID: 14758013
[TBL] [Abstract][Full Text] [Related]
2. Orally active CCR5 antagonists as anti-HIV-1 agents: synthesis and biological activity of 1-benzothiepine 1,1-dioxide and 1-benzazepine derivatives containing a tertiary amine moiety.
Seto M; Aramaki Y; Okawa T; Miyamoto N; Aikawa K; Kanzaki N; Niwa S; Iizawa Y; Baba M; Shiraishi M
Chem Pharm Bull (Tokyo); 2004 May; 52(5):577-90. PubMed ID: 15133211
[TBL] [Abstract][Full Text] [Related]
3. Orally active CCR5 antagonists as anti-HIV-1 agents. Part 3: Synthesis and biological activities of 1-benzazepine derivatives containing a sulfoxide moiety.
Seto M; Miyamoto N; Aikawa K; Aramaki Y; Kanzaki N; Iizawa Y; Baba M; Shiraishi M
Bioorg Med Chem; 2005 Jan; 13(2):363-86. PubMed ID: 15598559
[TBL] [Abstract][Full Text] [Related]
4. Orally active CCR5 antagonists as anti-HIV-1 agents 2: synthesis and biological activities of anilide derivatives containing a pyridine N-oxide moiety.
Seto M; Aramaki Y; Imoto H; Aikawa K; Oda T; Kanzaki N; Iizawa Y; Baba M; Shiraishi M
Chem Pharm Bull (Tokyo); 2004 Jul; 52(7):818-29. PubMed ID: 15256702
[TBL] [Abstract][Full Text] [Related]
5. Preparation of (4,4-difluoro-1,2,3,4-tetrahydro-5H-1-benzazepin-5-ylidene)acetamide derivatives as novel arginine vasopressin V(2) receptor agonists.
Tsukamoto I; Koshio H; Akamatsu S; Kuramochi T; Saitoh C; Yatsu T; Yanai-Inamura H; Kitada C; Yamamoto E; Sakamoto S; Tsukamoto S
Bioorg Med Chem; 2008 Nov; 16(21):9524-35. PubMed ID: 18835174
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological evaluation of chemokine receptor ligands with 2-benzazepine scaffold.
Thum S; Kokornaczyk AK; Seki T; De Maria M; Ortiz Zacarias NV; de Vries H; Weiss C; Koch M; Schepmann D; Kitamura M; Tschammer N; Heitman LH; Junker A; Wünsch B
Eur J Med Chem; 2017 Jul; 135():401-413. PubMed ID: 28463783
[TBL] [Abstract][Full Text] [Related]
7. (+/-)-3-[4'-(N,N-dimethylamino)cinnamyl]benzazepine analogs: novel dopamine D1 receptor antagonists.
Shah JH; Kline RH; Geter-Douglass B; Izenwasser S; Witkin JM; Newman AH
J Med Chem; 1996 Aug; 39(17):3423-8. PubMed ID: 8765528
[TBL] [Abstract][Full Text] [Related]
8. 'Click' D(1) receptor agonists with a 5-HT(1A) receptor pharmacophore producing D(2) receptor activity.
Zhang J; Zhang H; Cai W; Yu L; Zhen X; Zhang A
Bioorg Med Chem; 2009 Jul; 17(14):4873-80. PubMed ID: 19559623
[TBL] [Abstract][Full Text] [Related]
9. Discovery of potent, nonsystemic apical sodium-codependent bile acid transporter inhibitors (Part 1).
Tremont SJ; Lee LF; Huang HC; Keller BT; Banerjee SC; Both SR; Carpenter AJ; Wang CC; Garland DJ; Huang W; Jones C; Koeller KJ; Kolodziej SA; Li J; Manning RE; Mahoney MW; Miller RE; Mischke DA; Rath NP; Fletcher T; Reinhard EJ; Tollefson MB; Vernier WF; Wagner GM; Rapp SR; Beaudry J; Glenn K; Regina K; Schuh JR; Smith ME; Trivedi JS; Reitz DB
J Med Chem; 2005 Sep; 48(18):5837-52. PubMed ID: 16134950
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of 6-substituted 1-phenylbenzazepines and their dopamine D(1) receptor activities.
Zhang J; Chen X; Yu L; Zhen X; Zhang A
Bioorg Med Chem; 2008 Nov; 16(21):9425-31. PubMed ID: 18835172
[TBL] [Abstract][Full Text] [Related]
11. 4,10-dihydro-5H-thieno[3,2-c][1]benzazepine derivatives and 9,10-dihydro-4H-thieno[2,3-c][1]benzazepine derivatives as orally active arginine vasopressin receptor antagonists.
Aranapakam V; Albright JD; Grosu GT; Chan PS; Coupet J; Saunders T; Ru X; Mazandarani H
Bioorg Med Chem Lett; 1999 Jul; 9(13):1733-6. PubMed ID: 10406632
[TBL] [Abstract][Full Text] [Related]
12. Melanin-concentrating hormone receptor 1 antagonists: synthesis, structure-activity relationship, docking studies, and biological evaluation of 2,3,4,5-tetrahydro-1H-3-benzazepine derivatives.
Kasai S; Kamaura M; Kamata M; Aso K; Ogino H; Nakano Y; Watanabe K; Kaisho T; Tawada M; Nagisa Y; Takekawa S; Kato K; Suzuki N; Ishihara Y
Bioorg Med Chem; 2011 Nov; 19(21):6261-73. PubMed ID: 21975069
[TBL] [Abstract][Full Text] [Related]
13. Dopamine D1/D5 receptor antagonists with improved pharmacokinetics: design, synthesis, and biological evaluation of phenol bioisosteric analogues of benzazepine D1/D5 antagonists.
Wu WL; Burnett DA; Spring R; Greenlee WJ; Smith M; Favreau L; Fawzi A; Zhang H; Lachowicz JE
J Med Chem; 2005 Feb; 48(3):680-93. PubMed ID: 15689153
[TBL] [Abstract][Full Text] [Related]
14. Concise synthesis of 2-benzazepine derivatives and their biological activity.
So M; Kotake T; Matsuura K; Inui M; Kamimura A
J Org Chem; 2012 Apr; 77(8):4017-28. PubMed ID: 22463127
[TBL] [Abstract][Full Text] [Related]
15. A flexible approach for the preparation of substituted benzazepines: application to the synthesis of tolvaptan.
Cordero-Vargas A; Quiclet-Sire B; Zard SZ
Bioorg Med Chem; 2006 Sep; 14(18):6165-73. PubMed ID: 16782344
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological activities of novel furo[2,3,4-jk][2]benzazepin-4(3H)-one derivatives.
Ando K; Akai Y; Kunitomo J; Yokomizo T; Nakajima H; Takeuchi T; Yamashita M; Ohta S; Ohishi T; Ohishi Y
Org Biomol Chem; 2007 Feb; 5(4):655-63. PubMed ID: 17285174
[TBL] [Abstract][Full Text] [Related]
17. New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part 2: [g]-fused and hetero-fused systems.
Micheli F; Bonanomi G; Braggio S; Capelli AM; Damiani F; Di Fabio R; Donati D; Gentile G; Hamprecht D; Perini O; Petrone M; Tedesco G; Terreni S; Worby A; Heidbreder C
Bioorg Med Chem Lett; 2008 Feb; 18(3):908-12. PubMed ID: 18178090
[TBL] [Abstract][Full Text] [Related]
18. New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part one: [h]-fused tricyclic systems.
Micheli F; Bonanomi G; Braggio S; Capelli AM; Celestini P; Damiani F; Di Fabio R; Donati D; Gagliardi S; Gentile G; Hamprecht D; Petrone M; Radaelli S; Tedesco G; Terreni S; Worby A; Heidbreder C
Bioorg Med Chem Lett; 2008 Feb; 18(3):901-7. PubMed ID: 18248991
[TBL] [Abstract][Full Text] [Related]
19. Design and synthesis of trans-3-(2-(4-((3-(3-(5-methyl-1,2,4-oxadiazolyl))- phenyl)carboxamido)cyclohexyl)ethyl)-7-methylsulfonyl-2,3,4,5-tetrahydro-1H-3-benzazepine (SB-414796): a potent and selective dopamine D3 receptor antagonist.
Macdonald GJ; Branch CL; Hadley MS; Johnson CN; Nash DJ; Smith AB; Stemp G; Thewlis KM; Vong AK; Austin NE; Jeffrey P; Winborn KY; Boyfield I; Hagan JJ; Middlemiss DN; Reavill C; Riley GJ; Watson JM; Wood M; Parker SG; Ashby CR
J Med Chem; 2003 Nov; 46(23):4952-64. PubMed ID: 14584946
[TBL] [Abstract][Full Text] [Related]
20. GluN2B-selective N-methyl-D-aspartate (NMDA) receptor antagonists derived from 3-benzazepines: synthesis and pharmacological evaluation of benzo[7]annulen-7-amines.
Benner A; Bonifazi A; Shirataki C; Temme L; Schepmann D; Quaglia W; Shoji O; Watanabe Y; Daniliuc C; Wünsch B
ChemMedChem; 2014 Apr; 9(4):741-51. PubMed ID: 24677663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
